Tag: Diabetes: Misc.
mAb Glucagon Receptor Blocker Suitable for Further Development
REGN1193 inhibited glucose increase stimulated by glucagon in dose-dependent manner
July 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for July 2017. This roundup includes...
Benefit for Generalist + Specialist Care in Complex Conditions
Better outcomes for patients with compensated cirrhosis, diabetes who visit PCP and GI/ENDO
CDC: >100 Million Americans Have Diabetes or Prediabetes
Diabetes was seventh leading cause of death in 2015 in United States, according to report
Stem Cell Educator Therapy May Help Fight Diabetes
Stem cell therapy provided at least 4 years' benefit for some people with type 1 or type 2 diabetes
Resistance Training Improves Microvascular Blood Flow in T2DM
Muscle MBF response to the OGC increased after resistance training, and glycemic control improved
Intensive Lifestyle Changes May Up Frailty Fracture Risk in DM
But no increase in overall fracture risk with ILI in overweight or obese individuals with diabetes
Improved Glycemic Control With Eradication of Hepatitis C
Improved glycemic control, reduced antidiabetic medication use with sustained virologic response
Hyperbaric Oxygen Therapy Increasingly Being Used
Hyperbaric therapy increasing for diabetic wounds, although it is not recommended by ADA
Insulin Degludec Linked to Reduced Rate of Hypoglycemia
Reduced rate of hypoglycemic episodes among patients with type 1 diabetes, type 2 diabetes
